Liquidia Corporation (LQDA) Covered Calls

You can sell covered calls on Liquidia Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for LQDA (prices last updated Tue 4:16 PM ET):

Liquidia Corporation (LQDA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
20.07 +0.59 19.50 20.25 2.7M - 1.7
Covered Calls For Liquidia Corporation (LQDA)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Aug 15 20 1.95 18.30 9.3% 309%
Sep 19 20 2.80 17.45 14.6% 116%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Liquidia Corporation, through its subsidiaries, operates as a late-stage clinical biopharmaceutical company. The company focuses on the development and commercialization of various products using its PRINT technology that enables precise production of drug particles designed to enhance the safety, efficacy, and performance of a range of therapies. Its product candidates include LIQ861 for the treatment of pulmonary arterial hypertension; and LIQ865 for the treatment of local post-operative pain. The company also provides strategy, investment, and commercialization services for rare disease pharmaceutical products, such as generic Remodulin, a parenteral formulation of treprostinil for pulmonary arterial hypertension. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.